Elastic to Present in Upcoming Investor Conferences
Get Alerts ESTC Hot Sheet
Join SI Premium – FREE
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Elastic (NYSE: ESTC) (“Elastic”), the company behind Elasticsearch and the Elastic Stack, announced that Janesh Moorjani, Elastic's chief financial officer, will present at the following virtual investor conferences:
- Piper Sandler Global Technology Conference on Monday, September 13, 2021 at 7:30 a.m. PT / 10:30 a.m. ET
- Jefferies Virtual Software Conference on Tuesday, September 14, 2021 at 12:30 p.m. PT / 3:30 p.m. ET
- Citi 2021 Global Technology Virtual Conference on Wednesday, September 15, 2021 at 7:30 a.m. PT / 10:30 a.m. ET
A live webcast and replay of the event will be available on Elastic’s Investor Relations page at ir.elastic.co.
About Elastic
Elastic is a search company built on a free and open heritage. Anyone can use Elastic products and solutions to get started quickly and frictionlessly. Elastic offers three solutions for enterprise search, observability, and security, built on one technology stack that can be deployed anywhere. From finding documents to monitoring infrastructure to hunting for threats, Elastic makes data usable in real time and at scale. Founded in 2012, Elastic is a distributed company with Elasticians around the globe. Learn more at elastic.co.
Elastic and associated marks are trademarks or registered trademarks of Elastic N.V. and its subsidiaries. All other company and product names may be trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210830005529/en/
Anthony Luscri
Elastic Investor Relations
[email protected]
+1 650 695 1055
Lisa Boughner
Elastic Corporate Communications
[email protected]
Source: Elastic N.V.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rapaport Press Release: Small-Diamond Recovery Accelerates in June
- The 80/20 Institute Releases a 100-Day Playbook for PE-Backed CEOs Under Value-Creation Pressure
- LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer's Disease Presented at the Alzheimer's Association International Conference�
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Citi, Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share